Eli Lilly is acquiring psychedelic drug maker AtaiBeckley for up to $3.8 billion, indicating Big Pharma's growing interest in these treatments for mental health. This follows positive clinical trial results and a Trump executive order to fast-track FDA reviews, despite past regulatory hurdles.
A new book, "Getting Murdoched," by Andrew Dodd and Matthew Ricketson, details how Rupert Murdoch's media empire allegedly uses personal attacks and relentless campaigns to discredit critics. The book examines cases in the US, UK, and Australia, highlighting the severe personal and societal consequences of these tactics.
A new book, "Getting Murdoched," by Australian academics Andrew Dodd and Matthew Ricketson, details alleged "despicable" and "bullying" tactics used by Rupert Murdoch's global media empire, News Corp and Fox Corporation, across the UK, US, and Australia, highlighting personal attacks and a "chilling effect" on democracy.
The Food and Drug Administration said on Friday it will offer ultra-fast review to three psychedelic drugs being developed to treat mental health conditions, including depression, the latest indication of the Trump administration’s commitment to the experimental treatment approach. President Donald Trump signed an executive order last weekend directing the FDA and other federal agencies to speed access and loosen restrictions on psychedelics, a class of hallucinogenic drugs which remain illegal...
Trump signed an executive order Saturday to ease research restrictions on psychedelic drugs like psilocybin and LSD, aiming to accelerate studies into their potential for treating mental health conditions.
